Drug
TRPC inhibitor BI 1358894 clinical trials
Also written BI 1358894.
- studies test it
- 15
- open now
- 0
- in phase 3
- 0
- first study started
- 2017
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
15 studies that test it; most in 2020 (5)
| Year | Studies |
|---|---|
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 11
- Phase 2
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 0
Often tested with
Tested in the same studies.
Midazolam (1) · Citalopram (1) · Bupropion (1) · Itraconazole (1)
Studies
Open first, then newest update. How each study uses TRPC inhibitor BI 1358894 is read from its arms, and is right about nine times in ten.
Testing it · 15
- This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How BI 1358894 Affects the Way the Body Breaks Down MidazolamCompletedPhase 1Boehringer IngelheimNCT03754959Written as BI 1358894
- A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the BloodCompletedPhase 1Boehringer IngelheimNCT04426851Written as BI 1358894
- This Study in Healthy Men Tests How Different Doses of BI 1358894 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Looks at How Food Influences the Amount of BI 1358894 in the BloodCompletedPhase 1Boehringer IngelheimNCT03210272Written as BI 1358894
- A Study in Healthy Men to Test Whether BI 1358894 Reduces Druginduced Panic SymptomsCompletedPhase 1Boehringer IngelheimNCT03904576Written as BI 1358894
- A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With DepressionCompletedPhase 2Boehringer IngelheimNCT04521478Written as BI 1358894
- A Study in Healthy Men to Test if Taking Different Formulations of BI 1358894 With or Without Food Influences the Amount of BI 1358894 in the BloodCompletedPhase 1Boehringer IngelheimNCT03892616Written as BI 1358894 (B)
- A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the BodyCompletedPhase 1Boehringer IngelheimNCT04567316Written as BI 1358894
- A Study in Healthy People to Compare 2 Different Formulations of BI 1358894 Tablets Taken With or Without FoodCompletedPhase 1Boehringer IngelheimNCT05155306Written as BI 1358894, intended Commercial Formulation (iCF) (T)
- A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in EmotionsCompletedPhase 1Boehringer IngelheimNCT03854578Written as BI 1358894
- A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the BloodCompletedPhase 1Boehringer IngelheimNCT04899674Written as BI 1358894
- A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the BloodTerminatedPhase 1Boehringer IngelheimNCT05934942Written as BI 1358894
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 1358894 in the BloodCompletedPhase 1Boehringer IngelheimNCT03843151Written as BI 1358894
- A Study to Test Whether Taking BI 1358894 for 8 Weeks Helps Adults With Post-traumatic Stress DisorderCompletedPhase 2Boehringer IngelheimNCT05103657Written as BI 1358894
- A Study to Test Different Doses of BI 1358894 and Find Out Whether They Reduce Symptoms in People With Borderline Personality DisorderCompletedPhase 2Boehringer IngelheimNCT04566601Written as BI 1358894
- A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With DepressionTerminatedPhase 2Boehringer IngelheimNCT04423757Written as BI 1358894